Oscar Health, Inc. EBITDA for the Trailing 12 Months (TTM) ending June 30, 2025: USD -97.08 M

Oscar Health, Inc. EBITDA is USD -97.08 M for the Trailing 12 Months (TTM) ending June 30, 2025, a -220.48% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Oscar Health, Inc. EBITDA for the Trailing 12 Months (TTM) ending June 30, 2024 was USD 80.58 M, a -118.82% change year over year.
  • Oscar Health, Inc. EBITDA for the Trailing 12 Months (TTM) ending June 30, 2023 was USD -428.23 M, a -25.11% change year over year.
  • Oscar Health, Inc. EBITDA for the Trailing 12 Months (TTM) ending June 30, 2022 was USD -571.81 M, a 39.30% change year over year.
  • Oscar Health, Inc. EBITDA for the Trailing 12 Months (TTM) ending June 30, 2021 was USD -410.48 M.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)